Literature DB >> 28333905

[The inflammatory processes in atherogenesis].

Natalia Cichoń1, Dominika Lach1, Angela Dziedzic1, Michał Bijak1, Joanna Saluk1.   

Abstract

Atherogenesis is the process of atherosclerotic plaque formation, leading to coronary artery heart disease. This process involves immune cells, mainly T and B cells, monocytes and macrophages. The process of atherogenesis is induced by inflammatory damage of endothelial cells. The characteristic construction features of the atherosclerotic plaque is a predisposing factor for acute coronary syndromes. The accumulation of inflammatory cells in the artery inner membrane enhances the local inflammatory process due to the secretion of reactive oxygen species, inflammatory cytokines and metalloproteinases, which accelerate the development of atherosclerotic lesions in the arteries. In chronic inflammation of endothelial cells, which is atherosclerosis, there is a decrease in the concentration of elastin and collagen as a result of the increased apoptosis of smooth muscle cells of the intima. This reduces the integrity and strength of the fibrous cap that covers a layer of thrombogenic plaque from contact with blood elements. Permanent inflammation promotes the formation of necrotic core, composed of dead smooth muscle cells, macrophages and foam cells formed by phagocytosis of oxidized lipid molecules. The thin fibrous cap and a large necrotic core are the cause of plaque rupture and thrombus formation within the coronary artery.

Entities:  

Keywords:  atherogenesis; atherosclerotic plaque; inflammatory mediators

Mesh:

Year:  2017        PMID: 28333905

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  9 in total

Review 1.  Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.

Authors:  Carlos Manuel Zapata-Martín Del Campo; Martín Martínez-Rosas; Verónica Guarner-Lans
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

Review 2.  Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis.

Authors:  Yan Ren; Wei Qiao; Dongliang Fu; Zhiwei Han; Wei Liu; Weijie Ye; Zunjing Liu
Journal:  J Immunol Res       Date:  2017-09-06       Impact factor: 4.818

Review 3.  Natural Products as Modulators of Sirtuins.

Authors:  Berin Karaman Mayack; Wolfgang Sippl; Fidele Ntie-Kang
Journal:  Molecules       Date:  2020-07-20       Impact factor: 4.411

4.  The association between the serum level of vitamin D and ischemic heart disease: a study from Jordan.

Authors:  Mohamad I Jarrah; Nizar M Mhaidat; Karem H Alzoubi; Nasr Alrabadi; Enas Alsatari; Yousef Khader; Moath F Bataineh
Journal:  Vasc Health Risk Manag       Date:  2018-06-12

5.  Analysis for interaction between interleukin-35 genes polymorphisms and risk factors on susceptibility to coronary heart disease in the Chinese Han population.

Authors:  Hu Li; Ying-Xue Liu; Jin-Yan Huang; Yu-Feng Zhu; Kui Wang
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

6.  AGEs/RAGE Promote Osteogenic Differentiation in Rat Bone Marrow-Derived Endothelial Progenitor Cells via MAPK Signaling.

Authors:  Yuping Wang; Chunxia Jiang; Zhongming Shang; Guochun Qiu; Gang Yuan; Kaiqiang Xu; Qingchun Hou; Yanzheng He; Yong Liu
Journal:  J Diabetes Res       Date:  2022-02-01       Impact factor: 4.011

7.  Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress.

Authors:  Liwei Hang; Yan Peng; Rui Xiang; Xiangdong Li; Zhiliang Li
Journal:  Drug Des Devel Ther       Date:  2020-02-24       Impact factor: 4.162

Review 8.  A myriad of roles of dendritic cells in atherosclerosis.

Authors:  Yanfang Zhao; Jing Zhang; Wenjie Zhang; Yuekang Xu
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 5.732

9.  Intracoronary and peripheral blood levels of TNF-like Cytokine 1A (TL1A) in patients with acute coronary syndrome.

Authors:  Xinjing Chen; Yansong Guo; Li Lai; Shengli Zhang; Zhiliang Li
Journal:  Medicine (Baltimore)       Date:  2020-05-29       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.